Resources

5 Resources for

merger and sandoz

Subscribe to this listing via:
RSS
Email

Did you mean M&A (1,654 results), merger agreement (38 results), merger activity (5 results), merger announcement (1 results)

BNET Business Dictionary

Merger: the union of two or more organizations under single ownership, through the direct acquisition by one organization of the net assets or liabilities of the...; Merger definition on BNET »

BNET Resources

Common Enterprise Repository For R&D Documents Promises 144% Return on Investment: This article is about the Novartis, The merges of Swiss firms Sandoz and Ciba. It defines the requirements of the merger. Before the merger, employees at Sandoz had relied on a combination of paper files, local servers, PCs, and a VMS system to store their research documentation. The...; Tags: ROI, Novartis AG, R&D, Merger, Finance, Business Operations, Research & Development, Mergers & Acquisitions, Documentum, Sandoz, Investment; White papers 2003-01-01
Away win for the Morgans. (Morgan Stanley and JP Morgan's consultancy services in the Sandoz and Ciba merger): US investment banks JP Morgan and Morgan Stanley have acquired the right to provide financial advisory services to the merger of Swiss drug firms Sandoz and Ciba to form Novartis. As a result, questions were raised on why the firms have not acquired the services of Swiss banks. However, the...; Tags: chemicals, FINANCE, Investment, J.P. Morgan Chase & Co., merger, Morgan Stanley, Novartis AG, Sandoz; Research articles 1996-04-01
Sandoz, Ciba-Geigy to Slash Jobs Severely in Merger.(Originated from The Star-Ledger, Newark, N.J.): Dec. 14--As Sandoz Ltd. and Ciba-Geigy Ltd. look to complete their proposed $27 billion merger, the drug makers are about to slash huge numbers of workers in some of their departments. Dec. 14--As Sandoz Ltd. and Ciba-Geigy Ltd. look to complete ...; Tags: job, merger, Sandoz; Research articles 1996-12-14
The behemoth from Basle: drug mergers. (the merger of Swiss drug companies Sandoz and Ciba-Geigy will create Novartis, the world's second-largest drug company)(Brief Article): HOW do you create a world-class drugs company? Merge two medium-sized ones, sack 10,000 people and give the new entity the sort of name you would expect to find on a Japanese car. That, on the face of it, is what Switzerland's Sandoz and Ciba-Geigy areHOW do...; Tags: merger, Novartis AG, Sandoz; Research articles 1996-03-09
Novartis AG, formed by merger of Ciba-Geigy and Sandoz, establishes a sponsored ADR program: NEW YORK--BUSINESS WIRE--Dec. 23, 1996--Novartis AG, a new Swiss company formed by the recently completed merger of Ciba-Geigy and Sandoz, has established an American Depositary Receipt ADR program that will begin trading today in the over-the-counter OTC market under the symbol NWTSY. Each ADR represents one underlying American depositary...; Tags: merger, Novartis AG, Sandoz; Research articles 1996-12-23

Additional Resources

Thompson Hine Partner Frank Chaiken to Lead Corporate Transactions & Securities Practice: CINCINNATI -- Frank Chaiken, a partner in Thompson Hine's Cincinnati office, has been named the new chair of the firm's Corporate Transactions & Securities practice group. Chaiken, who joined Thompson Hine in 1993, is also a member of the firm's International Practice Committee. He previously led the firm's Private Companies...; Articles 2008-02-25
Consolidation pace steady as big companies get bigger: In order to compete with big brand-name drug companies, some generic manufacturers have consolidated to form juggernauts in the pharmaceutical industry. The biggest consolidation this year has been Mylan's $6.7 billion purchase of the generic business of Merck KGaA in May, to create a vertically and horizontally integrated...; Articles 2007-09-24
Ten years ago: * FTC allows the merger of Ciba and Sandoz to form Novartis. As part of the agreement, Sandoz sells its corn herbicide business to BASF. * Monsanto forms two separate publicly traded companies. Monsanto--a life sciences company that will serve the ag, food and health care markets, and...; Articles 2007-01-01
Foreign rivals queue to buy Mayne Pharma.: Byline: Nabila Ahmed Sep 20, 2006 (The Age - ABIX via COMTEX) -- Australian drug manufacturer Mayne Pharma is about to reveal on 21 September 2006 which overseas competitor has made a takeover offer. Speculation in the market has so far named...; Articles 2006-09-20
Mayne expected to endorse foreign bid.: Byline: Nabila Ahmed Sep 20, 2006 (The Sydney Morning Herald - ABIX via COMTEX) -- Australian drug manufacturer Mayne Pharma is about to reveal on 21 September 2006 which overseas competitor has made a takeover offer. Speculation in the market has so far...; Articles 2006-09-20
A Fourth Division for Novartis under the Title Vaccines & Diagnostics, Will Be Created After the Acquisition of Chiron Corporation.: M2 PRESSWIRE-30 August 2006-Research and Markets: A Fourth Division for Novartis under the Title Vaccines & Diagnostics, Will Be Created After the Acquisition of Chiron CorporationC1994-2006 M2 COMMUNICATIONS LTD RDATE:31082006 Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c41413) has announced the ...; Articles 2006-08-30
API leaves Woolies on the shelf.: Byline: Blair Speedy Dec 20, 2005 (The Australian - ABIX via COMTEX) -- Australian Pharmaceutical Industries API has denied any alliance with retailer, Woolworths. CEO Jeff Sher says his company ...; Articles 2005-12-20
Sandoz to focus on sales growth: MUNICH -- Sandoz, which recently completed the acquisition of Eon Labs Inc. and Hexal AG, anticipates additional mergers in the generic drug industry n but the company also sees itself as an exception to the trend. Chief executive Andreas Rummelt said in a recent interview that Sandoz, which...; Articles 2005-10-24
Vasella, Daniel 1953&#x2013;: Daniel Vasella 1953– Chairman, Novartis AG Nationality: Swiss. Born: November 1953, in Fribourg, Switzerland. Education: University of Berne, PhD, 1980. Family: Married Anne-Laurence (trustee, Foundation Switzerland di Cardiologia); children: three. Career: Sandoz Pharma, 1993, head of worldwide development; 1995–1996, CEO; Novartis, 1999–, chairman. Address: Novartis AG, 608 Fifth...; Articles 2005-01-01
A prescription for growth: Switzerland has always punched above its weight when it comes to the production of pharmaceuticals. Despite its small size the country's drugs sector has an impressive world market share of seven per cent: The history of the Swiss pharmaceuticals industry dates back to the middle of the 18th century, with Johann-Rudolf Geigy Gemuseus generally recognised as the pioneer with the establishment in 1758 of a Basel-based company that Waded in chemicals and drugs of any kind. Over the next hundred years,...; Articles 2004-10-01
Letter from the Editor: Mergers and acquisitions, albeit not mega takeovers, are back in the news this week, with QLT of Canada's $855 million bid for Atrix Laboratories, Par Pharmaceutical buying Kali Laboratories for $135 million and Bradley's purchase of Bioglan for $183 million. Also last week, Novartis' generics unit Sandoz made a $565...; Articles 2004-06-21
Vasella: most influential: A readers' poll conducted by the Financial Times' resulted in voting for Daniel Vasella as Europes's most influential business personality' over the last 25 years. The 50-year-old was appointed chief executive of Novartis in 1996, when the merger of Ciba and Sandoz created the Swiss pharmaceutical giant. ...; Articles 2004-05-01
Just what the doctor ordered! It's a small country, but Switzerland's pharmaceutical industry packs a global punch with a world market share of an astonishing seven per cent. Playing home to the likes of Novartis, Roche and Serono, the country remains an important centre for the pharmaceutical industry: The history of the drugs industry here in Switzerland goes back to the second half of the 18th century, with Johann-Rudolf Geigy Gemuseus, starting his chemical business in the city of Basel in 1758. Over the next hundred years, Basel, which benefited from its location on the border...; Articles 2003-10-01
Sandoz brand relaunch: Novartis plans to relaunch the Sandoz brand for generic pharmaceuticals. Novartis was formed by a merger of Sandoz and Ciba Geigey in 1996 and the Sandoz brand still commands wide respect, said the company...; Articles 2003-02-03
Indo-Swiss businessthen & now: Business ties between India and Switzerland have been developing and strengthening over the last few years. Ashwin Merchant, Deputy Director of the Swiss Business Hub India, provides Swiss News with an in-depth look at the economics between the two countries. Swiss News: Since when have India and Switzerland...; Articles 2002-11-01

<< Previous
page 1 of 1
Next >>

Content Types

Research articles (4 results)

White papers (1 results)

Resources

merger and sandoz

BNET Business Dictionary

BNET Resources

Additional Resources

Content Types

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors